Shaanxi Meibang Pharmaceutical Group Co., Ltd.

SHSE:605033 Stock Report

Market Cap: CN¥2.6b

Shaanxi Meibang Pharmaceutical Group Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 605033?
Owner TypeNumber of SharesOwnership Percentage
Institutions3,787,7462.8%
Private Companies18,224,90013.5%
General Public34,187,35425.3%
Individual Insiders79,000,00058.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 24 shareholders own 74.71% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
45.9%
Shaowu Zhang
62,100,000CN¥1.2b0%no data
6.66%
Tong Zhang
9,000,000CN¥174.3m0%no data
6.66%
Shaanxi Tongmei Industrial Co., Ltd.
9,000,000CN¥174.3m0%no data
5.84%
Qiufang Zhang
7,900,000CN¥153.0m0%no data
3.62%
Shaanxi Meifu Enterprise Management Partnership Enterprise (Limited Partnership)
4,890,000CN¥94.7m0%no data
2.6%
Shaanxi Meiping Enterprise Management Partnership Enterprise (Limited Partnership)
3,510,000CN¥68.0m0%no data
1.69%
China Asset Management Co. Ltd.
2,286,753CN¥44.3m0%0.01%
0.61%
Chengdu Qinxue Shansi Education Technology Co., Ltd
824,900CN¥16.0m0%no data
0.54%
Gfund Management Co., Ltd.
735,900CN¥14.3m0%0.04%
0.17%
CITIC Securities Company Limited, Asset Management Arm
229,191CN¥4.4m0%no data
0.12%
CITIC-Prudential Fund Management Company Ltd.
164,900CN¥3.2m0%0.01%
0.054%
Western Leadbank Fund Management Co., Ltd.
72,600CN¥1.4m0%0.01%
0.052%
Bank of Communications Schroder Fund Management Co., Ltd.
69,649CN¥1.3m0%no data
0.044%
China Merchants Fund Management Company Ltd.
59,800CN¥1.2m0%no data
0.038%
Taiping Fund Management Company Ltd.
51,000CN¥987.8k0%0.01%
0.038%
China Universal Asset Management Company Ltd.
50,746CN¥982.8k0%no data
0.019%
Truvalue Asset Management Co.,Ltd.
26,200CN¥507.5k0%no data
0.012%
Hongde Fund Management Co., Ltd.
15,600CN¥302.2k0%no data
0.007%
Lion Fund Management Co. Ltd.
9,469CN¥183.3k0%no data
0.0059%
Fortune And Royal Asset Management Co., Ltd.
8,000CN¥155.0k0%0.01%
0.0027%
ICBC Credit Suisse Asset Management Co., Ltd.
3,723CN¥72.0k0%no data
0.0019%
JP Morgan Asset Management
2,500CN¥48.4k0%no data
0.0013%
Penghua Fund Management Co., Ltd.
1,692CN¥32.7k0%no data
0.00002%
New China Fund Management Co., Ltd.
23CN¥523.80%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/09 14:48
End of Day Share Price 2025/01/09 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shaanxi Meibang Pharmaceutical Group Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution